1FALCK B, HILLARP N A, THIEME G, et al. Fluorescence of catecholamines and related compounds condensed with formaldehyde[J]. The Journal of Histochemistry and Cyto- chemistry, 1962,10 : 348-354.
2GERMAN D C, MANAYE K F. Midbrain dopaminergic neu- rons (nuclei A8, A9, and A10): three-dimensional recon- struction in the rat[J]. The Journal of Comparative Neurolo-gy, 1993,331:297-309.
3BOGERTS B, HANTSCH J, HERZER M. Amorphometric study of the dopamine-containing cell groups in the mesence- phalon of normals, Parkinson patients, and schizophrenics[J]. Biological Psychiatry, 1983,18 :951-969.
4CHINTA S J, ANDERSEN J K. Dopaminergie neurons[J]. The International Journal of Biochemistry&Cell Biology, 2005,37: 942-946.
5PARKINSON J. An essay on the slaaking palsy. 1817[J]. The Journal of Neuropsychiatry & Clinical Neurosciences, 2002,14 ; 222-236.
10Rodriguez-Oroz ME,Obeso JA,Lang AE,et al.Bilateral deep brain stimulation in Parkinson's disease:a multicentre study with 4 years follow-up.Brain,2005,128(Pt 10):2240-2249.
2SUAREZ F, ZHAO Q, MONAGHAN D T, et al. Functional heterogeneity o: NMDA receptors in rat substantia nigra parscompacta and reticulata neurones[J]. Eur J Neurosci, 2010,32 (3) :359-367.
3DINGLEDINE R, BORGES K, BOWIE D, et al. The glutamate receptor ion channels[J]. Pharmacol Rev, 1999,51(1) :7-61.
4CROOKS D R, WELCH N, SMITH D R. Low-level manga- nese exposure alters glutamate metabolism in GABAergic AF5 cell[J]. Toxieol Sei,2009,107 (3) : 156-164.
5CHENG F, LI X, LI Y, et al. Alpha-Synuclein promotes elathrin-mediated NMDA receptor endocytosis and attenuates NMDA-induced dopaminergic cell death [J]. J Neurochem, 2011,119(4) :815-825.
6KRESS G J, REYNOLDS I J. Dopaminergic neurotoxins re- quire exeitotoxic stimulation in organotypic cultures[J]. Neu- rohiol Dis, 2005,20(3):639-645.
7SAVITT J M, DAWSON V L, DAWSON T M. Diagnosis and treatment of Parkinson disease: molecules to medicine[J]. The Journal of Clinical Investigation, 2006,116(7) :1744-1754.
8FERRER I, LOPEZ-GONZALEZ I, CARMONA M, et al. Neurochemistry and the non-motor aspects of PD[J]. Neuro- biology of Disease, 2012,46(3) : 508-526.
9LIM S Y, LANG A E. The nonmotor symptoms of Parkinson' s disease-an overview[J]. Movement Disorders: Official Journal of the Movement Disorder Society, 2010,25(Suppl 1) : S123-S130.
10LEVY G, TANG M X, LOUIS E D, et al. The association of incident dementia with mortality in PD[J]. Neurology, 2002, 59(11) :1708-1713.
